Gene Therapy for the Treatment of Neurological Disorders: Central Nervous System Neoplasms-Reference-Cited by-同舟云学术

Gene Therapy for the Treatment of Neurological Disorders: Central Nervous System Neoplasms

Published:2016 Issue: Volume: Page:467-482
ISSN:1064-3745
Container-title:Gene Therapy for Neurological Disorders
language:
Short-container-title:

Author:

Kamran Neha,Candolfi Marianela,Baker Gregory J.,Ayala Mariela Moreno,Dzaman Marta,Lowenstein Pedro R.,Castro Maria G.

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4939-3271-9_31

Reference29 articles.

1. Candolfi M et al (2007) Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression. J Neurooncol 85(2):133–148

2. Castro MG et al (2011) Gene therapy and targeted toxins for glioma. Curr Gene Ther 11(3):155–180

3. King GD et al (2005) Gene therapy and targeted toxins for glioma. Curr Gene Ther 5(6):535–557

4. Radaelli E et al (2009) Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease. Histol Histopathol 24(7):879–891

5. Baker GJ et al (2014) Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy. Neoplasia 16(7):543–561

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gender Differences and miRNAs Expression in Cancer: Implications on Prognosis and Susceptibility;International Journal of Molecular Sciences;2023-07-17

2. Adult Diffuse Astrocytic and Oligodendroglial Tumors;Neurosurgery;2021-02-20

3. Transgenic increase in the β‐endorphin concentration in cerebrospinal fluid alleviates morphine‐primed relapse behavior through the μ opioid receptor in rats;Journal of Medical Virology;2019-02-19

4. A Blazing Landscape: Neuroinflammation Shapes Brain Metastasis;Cancer Research;2019-01-24

5. Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson’s disease model;npj Parkinson's Disease;2018-08-22